Sugyo, A.; Tsuji, A.B.; Sudo, H.; Koizumi, M.; Ukai, Y.; Kurosawa, G.; Kurosawa, Y.; Saga, T.; Higashi, T.
Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer. Int. J. Mol. Sci. 2018, 19, 2979.
https://doi.org/10.3390/ijms19102979
AMA Style
Sugyo A, Tsuji AB, Sudo H, Koizumi M, Ukai Y, Kurosawa G, Kurosawa Y, Saga T, Higashi T.
Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer. International Journal of Molecular Sciences. 2018; 19(10):2979.
https://doi.org/10.3390/ijms19102979
Chicago/Turabian Style
Sugyo, Aya, Atsushi B. Tsuji, Hitomi Sudo, Mitsuru Koizumi, Yoshinori Ukai, Gene Kurosawa, Yoshikazu Kurosawa, Tsuneo Saga, and Tatsuya Higashi.
2018. "Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer" International Journal of Molecular Sciences 19, no. 10: 2979.
https://doi.org/10.3390/ijms19102979
APA Style
Sugyo, A., Tsuji, A. B., Sudo, H., Koizumi, M., Ukai, Y., Kurosawa, G., Kurosawa, Y., Saga, T., & Higashi, T.
(2018). Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer. International Journal of Molecular Sciences, 19(10), 2979.
https://doi.org/10.3390/ijms19102979